PSC

Patient Square Capital Portfolio holdings

AUM $277M
1-Year Est. Return 6.76%
This Quarter Est. Return
1 Year Est. Return
+6.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$277M
AUM Growth
+$35.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$16M
2
+$2.87M
3
+$1.01M
4
CDTX icon
Cidara Therapeutics
CDTX
+$731K
5
ALLO icon
Allogene Therapeutics
ALLO
+$302K

Top Sells

1
+$6.26M
2
+$3.41M
3
+$1.66M
4
SLNO icon
Soleno Therapeutics
SLNO
+$1.33M
5
EYPT icon
EyePoint Pharmaceuticals
EYPT
+$1.22M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$12.4B
$141M 50.71%
12,480,000
INSM icon
2
Insmed
INSM
$33.7B
$36.1M 13.02%
358,800
+28,550
ARGX icon
3
argenx
ARGX
$50.3B
$16M 5.76%
+29,000
EYPT icon
4
EyePoint Pharmaceuticals
EYPT
$967M
$12.7M 4.59%
1,352,837
-129,140
LQDA icon
5
Liquidia Corp
LQDA
$1.93B
$12.7M 4.58%
1,020,000
-502,452
OCUL icon
6
Ocular Therapeutix
OCUL
$2.43B
$7.59M 2.74%
817,699
-102,500
CGEM icon
7
Cullinan Oncology
CGEM
$458M
$6.54M 2.36%
868,897
-10,000
KYMR icon
8
Kymera Therapeutics
KYMR
$4.19B
$6.11M 2.2%
140,000
-2,201
MIRM icon
9
Mirum Pharmaceuticals
MIRM
$3.52B
$5.77M 2.08%
113,462
-2,900
SRRK icon
10
Scholar Rock
SRRK
$2.85B
$5.45M 1.97%
154,000
ELVN icon
11
Enliven Therapeutics
ELVN
$1.22B
$4.93M 1.78%
245,838
-8,000
NRIX icon
12
Nurix Therapeutics
NRIX
$1.12B
$4.7M 1.69%
412,296
-35,000
AGIO icon
13
Agios Pharmaceuticals
AGIO
$2.52B
$4.65M 1.68%
139,732
PHVS icon
14
Pharvaris
PHVS
$1.48B
$4.3M 1.55%
244,283
-1,213
IRON icon
15
Disc Medicine
IRON
$3.2B
$3.92M 1.41%
74,000
-9,000
ALLO icon
16
Allogene Therapeutics
ALLO
$266M
$2.98M 1.07%
2,635,000
+266,814
GERN icon
17
Geron
GERN
$791M
$1.01M 0.36%
+716,000
CDTX icon
18
Cidara Therapeutics
CDTX
$2.36B
$731K 0.26%
+15,000
VYNE icon
19
VYNE Therapeutics
VYNE
$9.51M
$523K 0.19%
317,033
+60,000
BPMC
20
DELISTED
Blueprint Medicines
BPMC
– –
-38,500
NTLA icon
21
Intellia Therapeutics
NTLA
$2.75B
– –
-232,781
SLNO icon
22
Soleno Therapeutics
SLNO
$3.41B
– –
-18,600